The FDA on Tuesday issued a warning that the antipsychotic olanzapine may cause a rare but serious s...

The Food and Drug Administration (FDA) on Friday approved Nuplazid (pimavanserin) tablets, the first...

APA strongly supports the U.S. Food and Drug Administration’s proposed reclassification of electroco...

Five years after it last broached the matter, the Food and Drug Administration (FDA) is again propos...

The Food and Drug Administration (FDA) is extending deadlines for provider and pharmacy certificatio...

Last month, the FDA announced that beginning on October 12, all prescribers of clozapine—a medicatio...